ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2022

Schisandrin B Attenuates Diabetic Cardiomyopathy by Targeting MyD88 and Inhibiting MyD88-Dependent Inflammation.

Wu Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.